We have located links that may give you full text access.
English Abstract
Journal Article
Review
[Role of genetics in psychiatric treatment].
La Presse Médicale 2008 May
Psychopharmacogenetics was born with the development of psychotropic drugs in psychiatry, that is, slightly after the discovery of the role of lithium in bipolar disorders and of antipsychotic agents in schizophrenia. Psychopharmacogenetics relies on the analyses of the genes involved in treatment response adverse effects, efficacy, and their mechanisms. The utility of psychopharmacogenetics may be substantial. Being able to give each patient the appropriate dosage of the right treatment should enhance not only its immediate efficacy, but also compliance and therefore long-term efficacy. Psychopharmacogenetics nonetheless can provide only partial informations about the factors relevant to the best treatment; it will be a valuable tool for prescribers, without limiting their "know-how". Psychopharmacogenetic studies currently assess patients' capacity for acetylation or detoxification, coded by the NAT gene, whose genetic variants affect the metabolism of many psychotropic drugs.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app